R R

How Much Does Intraocular Pressure Drop After SLT Laser Treatment?

Selective Laser Trabeculoplasty (SLT) has become the gold standard first line treatment for open angle glaucoma and ocular hypertension. The procedure uses a cold laser to target specific pigmented cells in the trabecular meshwork, which is the drainage system of the eye. By stimulating a natural healing response, SLT improves the outflow of fluid and lowers intraocular pressure (IOP). In 2026, clinical guidelines increasingly recommend SLT over daily eye drops for newly diagnosed patients because it eliminates the issues of medication non compliance and ocular surface irritation.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

How Much Does Intraocular Pressure Drop After SLT Laser Treatment?

Selective Laser Trabeculoplasty (SLT) has become the gold standard first line treatment for open angle glaucoma and ocular hypertension. The procedure uses a cold laser to target specific pigmented cells in the trabecular meshwork, which is the drainage system of the eye. By stimulating a natural healing response, SLT improves the outflow of fluid and lowers intraocular pressure (IOP). In 2026, clinical guidelines increasingly recommend SLT over daily eye drops for newly diagnosed patients because it eliminates the issues of medication non compliance and ocular surface irritation.

read more about intraocular-pressure-drop-after-slt ...

Copy this HTML:

Copy HTML Copied!

Average Reduction in Millimeters of Mercury

On average, SLT laser treatment results in an intraocular pressure reduction of approximately 20 percent to 30 percent from the patient's baseline. In clinical terms, this typically equates to a drop of 4 mmHg to 8 mmHg for most patients. For example, a patient starting with a pressure of 24 mmHg can reasonably expect their pressure to settle between 17 mmHg and 19 mmHg after the laser has taken full effect. While these results are comparable to the efficacy of a primary prostaglandin eye drop, the specific reduction can vary based on the type of glaucoma and the initial pressure level.

Efficacy Based on Baseline Pressure

One of the most significant factors in determining the success of SLT is the patient's starting pressure. Clinical data suggests that patients with higher baseline IOP often experience a more dramatic absolute drop in millimeters of mercury. Conversely, patients with normal tension glaucoma or those whose pressures are already near the mid teens may see a smaller numerical drop. It is also important to note that the full effect of the laser is not instantaneous. Most clinicians wait six to eight weeks after the procedure to perform the final pressure check and determine the total success of the treatment.

Success Rates and Non Responders

The success rate for SLT is approximately 75 percent to 85 percent. This means the majority of patients will see a clinically significant drop in pressure that allows them to either avoid starting eye drops or reduce the number of medications they currently use. However, about 15 percent to 25 percent of patients are considered non responders, meaning the laser does not significantly lower their pressure. For these individuals, alternative treatments such as different laser types, different medication classes, or minimally invasive glaucoma surgery (MIGS) may be necessary.

Duration of the IOP Lowering Effect

The pressure lowering effect of SLT is not permanent, but it is typically long lasting. Studies show that the results generally persist for three to five years. One of the primary advantages of SLT is that it is repeatable. Because the cold laser does not cause thermal damage or scarring to the drainage tissues, the procedure can often be performed again once the initial effect begins to wear off. This repeatability makes SLT a vital tool for long term glaucoma management, as it can delay the need for more invasive surgical interventions for many years.

FAQs on SLT Pressure Drops

Can SLT completely replace my eye drops?

For many patients, especially those in the early stages of glaucoma, SLT can successfully control pressure without the need for supplemental drops. However, if your glaucoma is advanced, your doctor may use SLT in combination with medications to reach a safe target pressure that prevents further optic nerve damage.

What if my pressure doesn't drop enough?

If the first SLT treatment only provides a partial response, some surgeons may choose to treat the remaining 180 degrees of the drainage angle. If the pressure remains above the target after full treatment, the next step usually involves adding a topical medication or considering a MIGS procedure.

Is the pressure drop immediate?

No. While some patients show a small drop within the first few days, the biological remodeling of the drainage system takes time. The maximum IOP reduction is usually measured between two and three months after the laser application.

When to Discuss SLT with Your Ophthalmologist

If you have recently been diagnosed with high intraocular pressure or if you find it difficult to remember your daily eye drops, you should ask about SLT. Given the high success rate and the safety profile of the cold laser, it is often preferred over medications that can cause red eyes, stinging, or changes in the appearance of the skin around the eyes. Your doctor will perform a specialized exam called gonioscopy to ensure your drainage angle is open and suitable for the laser treatment.

References

https://www.glaucoma.org/treatment/selective-laser-trabeculoplasty-slt-10-common-questions.php
https://www.aao.org/eye-health/tips-prevention/laser-trabeculoplasty
https://pubmed.ncbi.nlm.nih.gov/30982630/